ConferenceSeries Ltd invites all the participants from all over the world to attend “International Conference on Hematology and Oncology” during June 29- July 01, 2017 in Thailand, Bangkok. The conference will be organized around the theme “Advances in Hematology and Oncology”.
Hematology and Oncology 2017 welcomes immunologists, pathologists, haematologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.
Hematologic Disorders
Hematology is the science dealing with blood, blood-forming organs and blood diseases also known as hematologic disorders. The therapeutic part of blood hematology is concerned with the treatment of blood issue and malignancies, including sorts of hemophilia, leukemia, lymphoma and sickle-cell iron deficiency. Red blood cell disorders are hematologic disorders that impact the red blood cells, the parts of the blood that carry oxygen from the lungs to all parts of the body. Hematology department itself is all kinds of study of the blood. White blood cells which are also known as White Blood Cells are the most important part of the body’s defense against foreign substances which may cause infectious diseases. For a healthy body a sufficient number of white blood cells present in the blood are important. Too many or very few WBC causes many disorders like Leukopenia which is caused by a decrease in WBC and Leukocytosis which is the increase in the count of WBC. Platelets help in wound healing and to prevent bleeding. The condition of low platelets count is known as Thrombocytopenia, Too many platelets in the blood leads to Blood clots. Plasma cells disorders are very rare. Plasma cells develop from B cells produces antibodies where there will be a clone in the antibody known as plasma disorder.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
7th World Hematology meetings, May 08-09, 2017 Barcelona, Spain; 9th International haematology conference, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; 14th Annual Mayo Clinic Hematology, January 21, 2017 Minneapolis, United States; 8th International Hematologic Malignancies Conference, January 21-23, 2017 Bangkok, Thailand; 11th Dutch Hematology Congress, January 25-27, 2017 Arnhem, Netherlands; Clinical and Multidisciplinary Hematology and Oncology, January 27-29, 2017 Scottsdale, United States; Belgian Hematological Society 32nd Annual General Meeting, January 27-28, 2017 Brussel, Belgium; ESMO 2017 Congress, September 8-12, 2017 Madrid, Spain.
Pediatric Hematology and Oncology
Pediatrics is the branch of medicine that deals with the medical care of infants, children, adolescents and the age limit usually ranges from birth up to 18 years of age medical practitioner who specializes in this area is known as a pediatrician. Pediatric Hematology is the branch of science that is the dealing of blood related problems in of infants, children and adolescents. The Division of Pediatric Hematology and Oncology cares for patients with diseases of the blood or blood-forming organs with the latest technologies and scientific discoveries, bolstered by a history of clinical excellence. The division maintains active clinical practices in both inpatient and outpatient units and provides a number of important services, including the Comprehensive Hemophilia Treatment.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology& Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology meetings April 24-25, 2017 Dubai, UAE; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th European Association for Hemophilia and Allied Disorders 10th Annual Congress, February 1-3, 2017 Paris, France; Society of Thrombosis and Hemostasis Research 61st Annual Meeting, February 15-18, 2017 Basel, Switzerland; 37th Annual Conference: Clinical hematology oncology, February 18-21, 2017 San Diego, United States; 7th Emirates Hematology meetings, March 16-18, 2017 Dubai, United Arab Emirates; British Society For Hematology conference Scientific Meeting, March 27-29, 2017
Hematopathology
Hematopathology is the branch of pathology which studies diseases of hematopoietic cells that is the blood cells. This includes the study of Molecular hematopoietic pathology, Metabolism of hematological cells, Clinical Biochemical Genetics and Genetic Molecular Pathology. The Hematopathology provides diagnostic services and specialized testing for patients with all types of leukemia, lymphoma and benign hematologic disorders. Cell Kinetics uses multicolor flow cytometry to immunophenotypically detect and characterize neoplastic hematolymphoid cells. Metabolic Hematology detects abnormal hemoglobins, red blood cell enzyme deficiencies and cytoskeletal abnormalities, Molecular Hematopathology analyzes RNA or DNA to detect and quantify genetic abnormalities useful in the diagnosis and monitoring of hematologic malignancies, Hematopathology Morphology performs complete blood counts and analyzes cellular morphology in peripheral blood hematology and some body fluids. Special Coagulation performs testing to aid in the diagnosis and treatment of patients who may have bleeding or clotting disorders. Special DNA Coagulation concentrates on the identification of genetic abnormalities associated with hereditary bleeding and clotting disorders.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
7th World Hematologists Congress, May 08-09, 2017 Barcelona, Spain; Global Oncology meetings & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncologists Meeting April 24-25, 2017 Dubai, UAE; International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, April 21-13, 2017 Prague, Czech Republic; Keystone Symposia: Hematopoiesis, January 31- February 4, 2017 Alberta, Canada; 19th International AEK oncology Congress, March 1-3, 2017 Heidelberg, Germany; XVII International Workshop on Chronic Lymphocytic leukemia conference, May 12-15, 2017 New York City, United States; International Conference on Advances in Oncology and Hematology, August 12-13, 2016 Coeur d'Alene, United States
Hematologic Oncology
Hematologic Oncology or Blood cancers affect the production and function of the blood cells known as blood hematology. Most of these cancers start in the bone marrow where blood is produced. Stem cells in your bone marrow mature and develop into three types of blood cells. In most hematologic cancer the normal blood cell development process is interrupted by uncontrolled growth of an abnormal type of blood cell. These abnormal blood cells also known as cancerous cells prevent your blood from performing many of its functions like fighting off infections or preventing serious bleeding. Acute lymphocytic leukemia is a cancer that starts from the early version of white blood cells called lymphocytes in the bone marrow. Acute Myeloid Leukemia which affects the blood and bone marrow and is characterized by an overproduction of immature white blood cells. Chronic lymphocytic leukemia is a type of cancer that starts from cells that become certain lymphocytes in the bone marrow these cancer cells start in the bone marrow but then go into the blood. Chronic Myeloid Leukemia affects the blood and bone marrow by producing too many white blood cells. Lymphoma is the type hematological cancers that develop in the lymphatic system. Myeloma also known as Multiple Myeloma arising from Plasma Cells. Myelodysplastic Syndromes are a group of diverse bone marrow disorders in which the bone marrow does not produce enough healthy blood cells.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
7th Inter American Oncology meetings, October 5-6, 2017 Buenos Aires, Argentina; 19th Meeting of the European Association for Haematopathology, September 29- October 4, 2017 Edinburgh, United Kingdom; ASH meetings of Hematologic Malignancies, September 8-9, 2017 Chicago, USA; 18th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy, September 15-18, 2017 Houston, USA; 3rd International Conference on Multiple Myeloma, October 7-9, 2017 Milan, Italy; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual oncology meetings April 24-25, 2017 Dubai, UAE.
Stem Cell/Bone Marrow Transplantation
Stem cell transplantation also known as Bone Marrow transplantation is mainly used to treat hematology oncology also known as Melanoma. Marrow is the soft, spongy tissue inside bones. It contains cells called hematopoietic stem cells. These cells can turn into several other types of cells. They can turn into more bone marrow cells and they can also turn into any type of blood cell. Certain cancers and other diseases keep hematopoietic stem cells from developing normally. A stem cell transplant gives new stem cells. The new stem cells can make new and healthy blood cells. An Autologous Transplant is a type of transplant that uses the person's own stem cells which are preserved earlier and used later. In an allogeneic transplant procedure the patient receives bone marrow or peripheral blood stem cells from another person. Umbilical cord blood is an alternative hematopoietic stem cell source for patients with hematologic disorders who can be cured by allogeneic hematopoietic cell transplantation. Human leukocyte antigen haplotype-mismatched transplant for hematological neoplasms is controversial.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
7th International Conference on Myeloproliferative Neoplasms, October 27 - 29, 2017 Estoril, Portugal; Clinical Updates on Aggressive Lymphoma, February 15 - 17, 2017 Paris, France; Training Course on WHO Classification: Towards Personalized Medicine in Hematology, March 09 - 11, 2017 Dublin, Ireland; 2nd Scientific Workshop on the Tumor Environment in Hematological Malignancies and its Therapeutic Targeting, April 07 - 09, 2017 Berlin, Germany; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on hematology association, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology& Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE.
Genetic disorders
Genes are known to cause many infectious as well as non-communicable diseases like cancer. In the same way genes also play a major role in hematologic disorders and blood diseases. Many genetic disorders in the formation of blood cells can also leads to hematologic cancer. Thalassemia is the inherited blood disorders that can result in the abnormal formation of hemoglobin. Sickle Cell Anemia is the severe hereditary form of anemia in which a mutated form of hemoglobin distorts the red blood cells into a crescent shape at low oxygen levels. Hemophilia is a rare bleeding disorder in which the blood doesn't clot normally. Hemoglobinopathy is a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
8th International Hematologic Malignancies Conference, January 21-23, 2017 Bangkok, Thailand; 11th Dutch Hematology Congress, January 25-27, 2017 Arnhem, Netherlands; Clinical and Multidisciplinary Oncology Hematology, January 27-29, 2017 Scottsdale, United States; Belgian hematology association 32nd Annual General Meeting, January 27-28, 2017 Brussel, Belgium; 14th Annual Mayo Clinic Hematology, January 21, 2017 Minneapolis, United States; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology& Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE.
Experimental and Clinical Hematology
Clinical Hematology for patients with hematologic disorders both benign and malignant besides providing laboratory hematology investigative and therapeutic backup. This mainly involves the study in the lab that is clinical analysis of anything related to hematology oncology clinic Instrumentation is very important. It includes general principles of human physiology and clinical laboratory operation as well as hematology topics such as blood cell formation, anemia, leukemia, coagulation disorders. In the Clinical Hematology the Quality control and Medical Significance is the prior.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
Clinical Updates on Aggressive Lymphoma, February 15 - 17, 2017 Paris, France; Training Course on WHO Classification: Towards Personalized Medicine in Hematology, March 09 - 11, 2017 Dublin, Ireland; 2nd Scientific Workshop on the Tumor Environment in Hematologic Malignancies and its Therapeutic Targeting, April 07 - 09, 2017 Berlin, Germany; 7th International Conference on Myeloproliferative Neoplasms, October 27 - 29, 2017 Estoril, Portugal; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE.
Hematology Diagnosis and Treatment
After the physical examination, for the detection of hematologic disorders Physician usually goes for Complete blood count (CBC). This is the basic test after that to diagnose a person's blood disorder, the doctor usually must do further hematology blood test Once a doctor finds that something is wrong with one or more of the blood cell types, many additional tests are available for further detection of disease. Hematology doctor can measure proportion of the different types of WBCs and can also determine subtypes of these cells by assessing certain markers on the surface of the cells. Tests are performed to measure the ability of white blood cells to fight foreign infection, to evaluate the functioning of blood platelets and their ability to clot and to check the contents of red blood cells to help determine the cause of anemia or why the cells are not functioning properly. Most of these tests are done on blood samples, but sometime require a bone marrow sample as well for Bone Marrow Examination. Once the problem is diagnosed Hematologists go for the appropriate treatment for particular problem. Now a days we have several methods to treat hematologic cancers such as Chemotherapy, Radiation therapy etc. Now a days advanced technique such as gene therapy is being used to treat Blood disorders. Researchers are attempting to search out ways that to correct the defective genes that cause Blood Disorders. Gene therapy hasn't nonetheless developed to the purpose that it's accepted treatment for Blood Disorder. However, researchers still take a look at gene therapy in clinical trials. Bone Marrow Transplantation, Hematopoietic stem cell therapy and Cord blood transplantation are new rising varieties of treatment for blood disorders.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
Training Course on WHO Classification: Towards Personalized Medicine in Hematology, March 09 - 11, 2017 Dublin, Ireland; 2nd Scientific Workshop on the Tumor Environment in Hematological Malignancies and its Therapeutic Targeting, April 07 - 09, 2017 Berlin, Germany; 7th International Conference on Myeloproliferative Neoplasms, October 27 - 29, 2017 Estoril, Portugal; Clinical Updates on Aggressive Lymphoma, February 15 - 17, 2017 Paris, France; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology& Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
7th Emirates Hematology Congress, March 16-18, 2017 Dubai, United Arab Emirates; British Society For hematology meetings: 57th Annual Scientific Meeting, March 27-29, 2017; European Association for Hemophilia and Allied Disorders 10th Annual Congress, February 1-3, 2017 Paris, France; Society of Thrombosis and Hemostasis Research 61st Annual Meeting, February 15-18, 2017 Basel, Switzerland; 37th Annual Conference: Clinical Hematology & Oncology, February 18-21, 2017 San Diego, United States; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE.
Clinical trials in Hematology
Hematology oncology researchers are making important discoveries in diverse fields, ranging from the most fundamental cellular investigations, to the most leading edge translational and clinical hematology research. New advances in oncology hematology treatment are occurring every day, giving patients hope that even greater discoveries lie ahead. Through clinical trials Diagnosing cancer has become more precise, Radiation and surgical techniques have advanced, Medications are more successful, Combinations of medical, surgical and radiation therapy are improving treatment effectiveness and enhancing outcomes. Strategies to address the late effects of cancer and hematology and its treatment are improving quality of life.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
International Conference on Advances in Hematology and Oncology, August 12-13, 2016 Coeur d'Alene, United States; European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, April 21-13, 2017 Prague, Czech Republic; Keystone Symposia: Hematopoiesis, January 31- February 4, 2017 Alberta, Canada; 19th International AEK Oncology Congress, March 1-3, 2017 Heidelberg, Germany; XVII International Workshop on Chronic Lymphocytic Leukemia, May 12-15, 2017 New York City, United States; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Cancer Meeting April 24-25, 2017 Dubai, UAE
Drug Discovery in Hematology
Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug repurposing represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical hematology testing for this new indication by leveraging their known pharmacology, pharmacokinetics and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies early-stage drug discovery projects. Here, several scientific approaches used to identify drug repurposing opportunities are highlighted with a focus on hematology malignancies. In addition a discussion of the regulatory issues that are unique to drug repurposing and how they impact developing old drugs for new indications is included. Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry and nonprofit charitable organizations are discussed.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
37th Annual Conference: Clinical Hematology & Oncology, February 18-21, 2017 San Diego, United States; 7th Emirates Hematology meetings, March 16-18, 2017 Dubai, United Arab Emirates; British Society For Hematology 57th Annual Scientific Meeting, March 27-29, 2017; European Association for Hemophilia and Allied Disorders 10th Annual Congress, February 1-3, 2017 Paris, France; Society of Thrombosis and Hemostasis Research 61st Annual Meeting, February 15-18, 2017 Basel, Switzerland; 7th World Hematologists Congress, May 08-09, 2017 Barcelona, Spain; 9th International Conference on Hematology, November 02-04, 2017 Las Vegas, USA; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE
Surgical Care
Surgical procedures can pose a risk for patients with bleeding disorders or clotting disorders. Simply know as hematologic disorders. There should be lot of care taken for the patients. It is important to involve a hematologist in pre and post-surgical care. The important and first step to take in the surgical care is to adjust the surgery as per the patient and form the Drug strategies according to that and blood transfusion at right time and finally clot filters which is known by hematology blood test.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
Clinical Updates on Aggressive Lymphoma, February 15 - 17, 2017 Paris, France; Training Course on WHO Classification: Towards Personalized Medicine in Hematology, March 09 - 11, 2017 Dublin, Ireland; 2nd Scientific Workshop on the Tumor Environment in Hematologic Malignancies and its Therapeutic Targeting, April 07 - 09, 2017 Berlin, Germany; 7th International Conference on Myeloproliferative Neoplasms, October 27 - 29, 2017 Estoril, Portugal; 7th World Hematology Congress, May 08-09, 2017 Barcelona, Spain; 9th International Haematology Conference, November 02-04, 2017 Las Vegas, USA; Global oncology meetings & Cancer May 25-27, 2017 Osaka, Japan; International Conference and Expo on Cancer Biomarkers August 07-09, 2017 Osaka, Japan; 16th Global Annual Oncology Meetings April 24-25, 2017 Dubai, UAE.
Types of Cancer
The name of cancer is based on the location of cancer cells occur in particular organ. There are more than 200 different types of cancer diagnosed. Among them Lung cancer, breast cancer are the most common cancer diagnosed cancer. Apart from these Prostate Cancer, Colon Cancer, Bladder Cancer, Oral Cancer, Gynecologic Cancer, Skin Cancer, Bone Cancer, Thyroid Cancer, Gastro-intestinal Cancer and lung cancer are the most common type cancer. Depending upon the location of cancer the causes, symptoms and method of treatments varies. Carcinoma, Sarcoma, leukemia, lymphoma and melanoma are the types of cancer found in different organs.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; 9th International Conference and Expo on Molecular & Cancer Biomarkers, August 23-24, 2017 Birmingham, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; World Congress on Preventive oncology, July 20-21, 2017 Chicago, USA; ESMO 2017 Congress, September 8-12, 2017 Madrid, Spain; ESMO Symposium on Signalling Pathways in Cancer in Partnership with the EACR, March 17-18, 2017 Barcelona, Spain; American Association of Cancer Research (AACR) Annual Meeting 2017; Irish Association for Cancer Research Annual Cancer Conference, February 22-24, 2017 Kilkenny, Ireland; 7th InterAmerican Oncology Conference, October 5-6, 2017; Buenos Aires, Argentina; ECCO2017: European Cancer Congress, January 27-30, 2017 Amsterdam, Netherlands
Tumor Pathology
Tumor pathology deals with the pathology reports that contain the cancer examining cells and tissues. Pathology reports give the information about the types of tumor or cancer. Weather the tissue or cell is cancerous or not, where the cancer started, different types of cancer such as melanoma, carcinoma and lymphoma is determined by the pathology reports. For classification, management and diagnosis of cancers like non-Hodgkin lymphoma, leukemia flowcytometry can be used.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
Global Experts meeting on Oncology Case Reports, Aug 29-31, 2017 London, UK; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; 19th World Cancer Conference, Nov 21-23, 2017 London, UK; 11th International Conference on Leukemia and Hematologic Oncology, December 04-05, 2017 Madrid, Spain; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE; AEK 19th International Cancer Congress, March 1-3, 2017 Heidelberg, Germany; Primary and Secondary Brain Tumors Conference, February 19-20, 2017 Madrid, Spain; 15th St Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer, March 15-18, 2017 Vienna, Austria; Genes and Cancer – 32nd Annual meeting, April 10-12, 2017 Cambridge, UK; Cell Symposia: Cancer, Inflammation, and Immunity, June 11-13, 2017 San Diego, USA
Hematology and Oncology Experts Meeting
This session is designed to share important information and latest advancements related to hematologic disorders, hematology oncology and various types of cancers and the issues with Hematology which discuss about the Patients and Public Involvement, Quality Improvement, Clinical Outcomes of the topics related and Tips and Tricks for the treatments.
Related Conferences: Hematology Conferences | Cancer Conferences | Worldwide Cancer events | Upcoming Hematology meetings
19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; 9th International Conference and Expo on Molecular & Cancer Biomarkers, August 23-24, 2017 Birmingham, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain; World Congress on Preventive oncology, July 20-21, 2017 Chicago, USA; International Conference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; ESMO 2017 Congress, September 8-12, 2017 Madrid, Spain; ESMO Symposium on Signalling Pathways in Cancer in Partnership with the EACR, March 17-18, 2017 Barcelona, Spain; American Association of Cancer Research (AACR) Annual Meeting 2017; Irish Association for Cancer Research Annual Cancer meetings, February 22-24, 2017 Kilkenny, Ireland; 7th InterAmerican oncology congress October 5-6, 2017; Buenos Aires, Argentina; ECCO2017: European Cancer Congress, January 27-30, 2017 Amsterdam, Netherlands
